Literature DB >> 28582856

Lipidomic Profiles in Diabetes and Dementia.

Kevin Huynh1,2, Ralph N Martins3,4, Peter J Meikle1,2.   

Abstract

Lipids are a diverse class of hydrophobic and amphiphilic molecules which make up the bulk of most biological systems and are essential for human life. The role of lipids in health and disease has been recognized for many decades, as evidenced by the early identification of cholesterol as an important risk factor of heart disease and the development and introduction of statins as a one of the most successful therapeutic interventions to date. While several studies have demonstrated an increased risk of dementia, including Alzheimer's disease (AD), in those with diabetes mellitus, the nature of this risk is not well understood. Recent developments in the field of lipidomics, driven primarily by technological advances in high pressure liquid chromatography and particularly mass spectrometry, have enabled the detailed characterization of the many hundreds of individual lipid species in mammalian systems and their association with disease states. Diabetes mellitus and AD have received particular attention due to their prominence in Western societies as a result of the ongoing obesity epidemic and the aging populations. In this review, we examine how these lipidomic studies are informing on the relationship between lipid metabolism with diabetes and AD and how this may inform on the common pathological pathways that link diabetes risk with dementia.

Entities:  

Keywords:  Alzheimer’s disease; diabetes mellitus; lipid metabolism; mass spectrometry; risk

Mesh:

Substances:

Year:  2017        PMID: 28582856     DOI: 10.3233/JAD-161215

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

1.  Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.

Authors:  Xueheng Zhao; Marion G Brusadelli; Sharon Sauter; Melinda Butsch Kovacic; Wujuan Zhang; Lindsey E Romick-Rosendale; Paul F Lambert; Kenneth D R Setchell; Susanne I Wells
Journal:  Clin Cancer Res       Date:  2018-03-12       Impact factor: 12.531

2.  Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial.

Authors:  Cristina Razquin; Estefanía Toledo; Clary B Clish; Miguel Ruiz-Canela; Courtney Dennis; Dolores Corella; Christopher Papandreou; Emilio Ros; Ramon Estruch; Marta Guasch-Ferré; Enrique Gómez-Gracia; Montserrat Fitó; Edward Yu; José Lapetra; Dong Wang; Dora Romaguera; Liming Liang; Angel Alonso-Gómez; Amy Deik; Mónica Bullo; Lluis Serra-Majem; Jordi Salas-Salvadó; Frank B Hu; Miguel A Martínez-González
Journal:  Diabetes Care       Date:  2018-10-16       Impact factor: 19.112

3.  Chemical Derivatization-Aided High Resolution Mass Spectrometry for Shotgun Lipidome Analysis.

Authors:  Vinzenz Hofferek; Huaqi Su; Gavin E Reid
Journal:  Methods Mol Biol       Date:  2021

4.  Occult hypoperfusion and changes of systemic lipid levels after severe trauma: an analysis in a standardized porcine polytrauma model.

Authors:  Yohei Kumabe; Yannik Kalbas; Sascha Halvachizadeh; Michel Teuben; Nikola Cesarovic; Miriam Weisskopf; Andreas Hülsmeier; Thorsten Hornemann; Paolo Cinelli; Hans-Christoph Pape; Roman Pfeifer
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-12       Impact factor: 2.374

Review 5.  Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics.

Authors:  Sampara Vasishta; Kailash Ganesh; Shashikiran Umakanth; Manjunath B Joshi
Journal:  Metabolomics       Date:  2022-06-28       Impact factor: 4.747

6.  Metformin and the risk of dementia based on an analysis of 396,332 participants.

Authors:  Shiliang Ji; Xingxing Zhao; Ruifang Zhu; Yongchao Dong; Lifeng Huang; Taiquan Zhang
Journal:  Ther Adv Chronic Dis       Date:  2022-07-09       Impact factor: 4.970

7.  High-throughput liquid chromatography mass-spectrometry-driven lipidomics discover metabolic biomarkers and pathways as promising targets to reveal the therapeutic effects of the Shenqi pill.

Authors:  Wen-Xiu Li; Ai-Hua Zhang; Xiao-Hang Zhou; Yang Nan; Qi Liu; Hui Sun; Heng Fang; Xi-Jun Wang
Journal:  RSC Adv       Date:  2020-01-13       Impact factor: 4.036

8.  Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease.

Authors:  Mostafa J Khan; Nadjali A Chung; Shania Hansen; Logan Dumitrescu; Timothy J Hohman; M Ilyas Kamboh; Oscar L Lopez; Renã A S Robinson
Journal:  Anal Chem       Date:  2022-03-02       Impact factor: 8.008

9.  Plasma Lipidomic Profiles and Risk of Diabetes: 2 Prospective Cohorts of HIV-Infected and HIV-Uninfected Individuals.

Authors:  Eric Zhang; Jin Choul Chai; Amy A Deik; Simin Hua; Anjali Sharma; Michael F Schneider; Deborah Gustafson; David B Hanna; Jordan E Lake; Leah H Rubin; Wendy S Post; Kathryn Anastos; Todd Brown; Clary B Clish; Robert C Kaplan; Qibin Qi
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 6.134

10.  Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.

Authors:  Pol Andrés-Benito; Ellen Gelpi; Mariona Jové; Natalia Mota-Martorell; Èlia Obis; Manuel Portero-Otin; Mònica Povedano; Aurora Pujol; Reinald Pamplona; Isidro Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.